The opioid growth factor (OGF)-OGF receptor axis uses the p16 pathway to inhibit head and neck cancer
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Michael F. Verderame |
| Publication date | November 1, 2007 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |